On Monday morning, Novo Nordisk, the makers of the GLP-1 drug semaglutide (Ozempic and Wegovy), and Hims & Hers Health Inc. jointly announced a ceasefire to their growing hostilities via a new ...
Kivo reports that new drug access varies by state, with delays ranging from two to five months after FDA approval, impacting ...
Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results